Search Results - "PETERSEN, Andreas Munk"

Refine Results
  1. 1

    Can fecal microbiota transplantation cure irritable bowel syndrome? by Halkjær, Sofie Ingdam, Boolsen, Anders Watt, Günther, Stig, Christensen, Alice Højer, Petersen, Andreas Munk

    Published in World journal of gastroenterology : WJG (14-06-2017)
    “…AIM To verify the utility of treatment with fecal microbiota transplantation(FMT) in patients with irritable bowel syndrome(IBS).METHODS We searched EMBASE,…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Faecal microbiota transplantation alters gut microbiota in patients with irritable bowel syndrome: results from a randomised, double-blind placebo-controlled study by Halkjær, Sofie Ingdam, Christensen, Alice Højer, Lo, Bobby Zhao Sheng, Browne, Patrick Denis, Günther, Stig, Hansen, Lars Hestbjerg, Petersen, Andreas Munk

    Published in Gut (01-12-2018)
    “…IBS is associated with an intestinal dysbiosis and faecal microbiota transplantation (FMT) has been hypothesised to have a positive effect in patients with…”
    Get more information
    Journal Article
  4. 4

    Epidemiology and Clinical Manifestations of Enteroaggregative Escherichia coli by JENSEN, Betina Hebbelstrup, OLSEN, Katharina E. P, STRUVE, Carsten, KROGFELT, Karen Angeliki, PETERSEN, Andreas Munk

    Published in Clinical microbiology reviews (01-07-2014)
    “…Enteroaggregative Escherichia coli (EAEC) represents a heterogeneous group of E. coli strains. The pathogenicity and clinical relevance of these bacteria are…”
    Get full text
    Journal Article
  5. 5

    Inflammatory Bowel Disease Patients Are at Increased Risk of Invasive Pneumococcal Disease: A Nationwide Danish Cohort Study 1977-2013 by Kantsø, Bjørn, Simonsen, Jacob, Hoffmann, Steen, Valentiner-Branth, Palle, Petersen, Andreas Munk, Jess, Tine

    Published in The American journal of gastroenterology (01-11-2015)
    “…Inflammatory bowel disease (IBD), Crohn's disease (CD), and ulcerative colitis (UC) are chronic diseases characterized by an inappropriate immune response,…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    The Role of the Gut Microbiome in Urinary Tract Infections: A Narrative Review by Iqbal, Zaryan Safdar, Halkjær, Sofie Ingdam, Ghathian, Khaled Saoud Ali, Heintz, Julie Elm, Petersen, Andreas Munk

    Published in Nutrients (24-10-2024)
    “…Background/Objectives: Urinary tract infections (UTIs) represent a substantial health concern worldwide. Although it is known that the gut can act as a…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12

    The Effect of Antibiotics on the Eradication of Multidrug-Resistant Organisms in Intestinal Carriers-A Systematic Review with Meta-Analysis by Knudsen, Maja Johanne Søndergaard, Rubin, Ingrid Maria Cecilia, Petersen, Andreas Munk

    Published in Antibiotics (Basel) (09-08-2024)
    “…The aim of this systematic review was to investigate the effect of antibiotics on the eradication of multidrug-resistant organisms (MRO) in intestinal…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16

    Systematic review with meta-analysis: encapsulated faecal microbiota transplantation – evidence for clinical efficacy by Cold, Frederik, Baunwall, Simon Mark Dahl, Dahlerup, Jens Frederik, Petersen, Andreas Munk, Hvas, Christian Lodberg, Hansen, Lars Hestbjerg

    “…Background: Faecal microbiota transplantation (FMT) is an effective treatment of recurrent Clostridioides difficile infection (rCDI) and is being applied…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    The Efficacy of Faecal Microbiota Transplant and Rectal Bacteriotherapy in Patients with Recurrent Clostridioides difficile Infection: A Retrospective Cohort Study by Svensson, Camilla Kara, Cold, Frederik, Ribberholt, Iben, Zangenberg, Mike, Mirsepasi-Lauridsen, Hengameh Chloé, Petersen, Andreas Munk, Helms, Morten

    Published in Cells (Basel, Switzerland) (18-10-2022)
    “…The most effective treatment for recurrent infection (CDI) is faecal microbiota transplantation (FMT); however, the optimal route of administration is thus far…”
    Get full text
    Journal Article
  20. 20

    Comparison of three commercial fecal calprotectin ELISA test kits used in patients with Inflammatory Bowel Disease by Mirsepasi-Lauridsen, Hengameh Chloé, Bachmann Holmetoft, Ulla, Ingdam Halkjær, Sofie, Angeliki Krogfelt, Karen, Munk Petersen, Andreas

    Published in Scandinavian journal of gastroenterology (01-02-2016)
    “…Objective: Fecal calprotectin is a noninvasive marker of intestinal inflammation used to distinguish between functional and organic bowel diseases and to…”
    Get full text
    Journal Article